Teresa Morán

7PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.

|Nov 27, 2024
Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors.

Roser Salvia, Laura G Rico, Teresa Morán

|Jan 12, 2024
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?

Sviatoslav Chekhun, Assumpció Lopez-Paradís, Aintzane Urbizu

|Nov 07, 2023
Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer.

Thomas A Odeny, Kathryn Lurain, Julius Strauss

|Jan 08, 2023
Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study.

Ainhoa Hernandez, Marc Boigues, Eudald Felip

|Dec 10, 2022
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.

Eudald Felip, Edwards Pradenas, Margarita Romeo

Pageof 2

Frequent Collaborators

2 joint publications

Eudald Felip

2 joint publications

Maria Gonzalez-Cao

1 joint publications

Pilar Garrido

1 joint publications

José Luis González-Larriba